Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -342,117 | 112,602 | -525,192 | 151,118 | -55,783 |
| Depreciation Amortization | 418,426 | 103,760 | 800,315 | 86,411 | 82,586 |
| Income taxes - deferred | -42,342 | 16,845 | 7,872 | -12,510 | 4,035 |
| Accounts receivable | -5,640 | 21,082 | -11,171 | -492 | -18,961 |
| Accounts payable and accrued liabilities | 71 | -11,349 | 8,321 | 2,076 | -2,586 |
| Other Working Capital | 7,556 | -43,575 | -32,599 | 18,931 | -58,618 |
| Other Operating Activity | 132,282 | 16,212 | 28,020 | 46,793 | 225,300 |
| Operating Cash Flow | $168,236 | $215,577 | $275,566 | $292,327 | $175,973 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -42,860 | -79,853 | -198,642 | -230,938 | -181,617 |
| Net Acquisitions | N/A | -83,347 | -69,151 | -11,584 | -30,862 |
| Purchase Of Investment | -27,600 | -98,991 | -6,439 | -299,408 | -207,900 |
| Sale Of Investment | 72,464 | 50,484 | 45,444 | 334,546 | 122,981 |
| Other Investing Activity | 950 | 2,623 | 51 | 2,668 | 0 |
| Investing Cash Flow | $2,954 | $-209,084 | $-228,737 | $-204,716 | $-297,398 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 579,372 | 18,000 | 102,000 | N/A | 440,300 |
| Debt Repayment | -381,535 | -54,130 | -36,540 | -64,545 | -170,842 |
| Common Stock Issued | 4,492 | 819 | 28,141 | 53,977 | 22,900 |
| Common Stock Repurchased | -356,527 | -45,897 | -115,058 | -41,617 | -249,958 |
| Other Financing Activity | -13,697 | 231 | 3,788 | 5,758 | -36,832 |
| Financing Cash Flow | $-167,895 | $-80,977 | $-17,669 | $-46,427 | $5,568 |
| Exchange Rate Effect | -10,293 | 3,736 | -17,310 | 13,032 | -1,205 |
| Beginning Cash Position | 182,574 | 243,592 | 225,449 | 175,380 | 114,821 |
| End Cash Position | 179,160 | 182,574 | 243,592 | 225,449 | 175,380 |
| Net Cash Flow | $-3,414 | $-61,018 | $18,143 | $50,069 | $60,559 |
| Free Cash Flow | |||||
| Operating Cash Flow | 168,236 | 215,577 | 275,566 | 292,327 | 175,973 |
| Capital Expenditure | -42,860 | -79,853 | -198,642 | -230,938 | -181,747 |
| Free Cash Flow | 125,376 | 135,724 | 76,924 | 61,389 | -5,774 |